The efficacy of semaglutide as a weight loss treatment option has been demonstrated in several clinical trials, including the SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) and PIONEER (Peptide Innovation for Early Diabetes Treatment) trials for type 2 diabetes, as well as the STEP (Semaglutide Treatment Effect in People with Obesity) trials, which specifically focused on weight loss
The peptide is useful in comparisons between single-, dual-, and triple-agonist strategies across various endpoints: Food Intake and Appetite Regulation Energy Expenditure and Substrate Utilization Glucose Pathway Regulation and Insulin Secretion Dynamics Lipid Handling and Metabolic Flexibility Retatrutide also provides a structured context for research into dose-response relationships, safety monitoring, and the durability of metabolic changes
You can inject sitting or standing
The form is important because incomplete or missing information can delay review, and submission does not guarantee approval
This timing recommendation is based on the medication's short-acting profile and its mechanism of slowing gastric emptying, which is most beneficial when timed with food intake